China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study of the Efficacy and Safety of Maribavir for Cytomegalovirus (CMV) Infection Following Hematopoietic Stem Cell Transplantation in Children and Adolescents'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133417
Registration Time: 2026/09/26
Type: Interventional study
Primary Sponsor: Children's Hospital of Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342410
Published by HT Digital Content Services with permission from Health Daily Digest....